Prognosis of a protein METTL-14 in endometrial cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study looks at how a specific protein (METTL-14) may affect the outlook for women with Type 1 endometrial cancer. It uses stored tissue and medical records to see if this protein can help predict survival or spread of the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a hysterectomy (surgery to remove the uterus) for your endometrial cancer.
- Your cancer must be classified as Type 1 (the most common type).
- You need to have complete medical records, including symptoms, exam findings, biopsy results, and imaging (like ultrasound or MRI).
- Full follow-up data for 3 years after diagnosis and treatment, including survival, disease progression, and any chemotherapy history.
- You must have a tissue sample (in a paraffin block or stained slide) from your surgery available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at women with certain high-risk types of endometrial cancer that have not spread into the muscle wall of the uterus. It aims to understand how these cancers behave and whether lymph node testing is needed, which could help guide treatment decisions.
This study is testing whether a special kind of medicine called a PARP inhibitor can work against endometrial cancer cells grown in a lab from your tumor. The goal is to find out which patients might benefit from this treatment in the future.
This trial tests a tailored approach to preserve fertility in women with early-stage endometrial cancer, using medications like hormones and immunotherapy based on the tumor's molecular subtype. It aims to avoid hysterectomy and keep the uterus intact.
This study looks at combining genetic testing with surgical exams to better understand endometrial cancer. It may help doctors see which treatments could work best for you.
This study looks at the specific type of endometrial cancer (endometrioid) in Mexican patients to understand how different molecular features affect prognosis. It may help doctors better tailor treatment to the individual.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.